| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.00015 | 1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0002 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 9.4e-05 | 1 |